Cleveland Diagnostics
PrivateLast Round
Series E
Jan 17, 2024
Est. Valuation
$13.2M
Total Funding Raised
$77M
Company Overview
Cleveland Diagnostics is a biotechnology company that develops non-invasive diagnostic tests for early cancer detection using a proprietary platform that analyzes protein structural changes.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Precision Medicine
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cleveland Diagnostics Comparables
Compare Cleveland Diagnostics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| LynxDx | 83% | |
| MDxHealth | 81% | |
| MiRNA Scientific | 80% | |
Cleveland Diagnostics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series E | Jan 17, 2024 | ||||
| Convertible Debt | Feb 9, 2021 | ||||
| Convertible Debt | Nov 28, 2017 | ||||
| VC Round | Nov 21, 2016 | ||||
| VC Round | Mar 20, 2015 |
Cleveland Diagnostics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Serial Stage Venture Partners | Series E |
| Genomic Health | Convertible Debt |
| Cleveland Clinic Ventures | Convertible Debt, Series E |
| LYFE Capital | Convertible Debt |
| Symbiotic Capital | Series E |
| Novo Holdings | Series E |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 1, 2026
IsoPSA Test for Prostate Cancer gains FDA approval.
- Mar 1, 2026
Launched FDA-approved IsoPSA Test for Prostate Cancer nationwide.
Cleveland Diagnostics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Cleveland Diagnostics's valuation, stock price, and market status.